Table-6.
Oil adjuvant | Mitogen and used virus | Percentage of lymphocyte proliferation/days post vaccination | |||||
---|---|---|---|---|---|---|---|
3rd | 7th | 14th | 21th | 28th | 35th | ||
Montanide ISA 201 oil vaccine | PHA | 0.275 | 0.311 | 0.395 | 0.344 | 0.285 | 0.214 |
FMDV | 0.365 | 0.438 | 0.460 | 0.441 | 0.351 | 0.272 | |
Montanide ISA 206 oil vaccine | PHA | 0.245 | 0.310 | 0.344 | 0.375 | 0.295 | 0.211 |
FMDV | 0.295 | 0.315 | 0.395 | 0.428 | 0.321 | 0.251 | |
Montanide ISA 61 oil vaccine | PHA | 0.255 | 0.310 | 0.335 | 0.375 | 0.260 | 0.219 |
FMDV | 0.335 | 0.395 | 0.435 | 0.455 | 0.335 | 0.291 | |
Montanide ISA 50 oil vaccine | PHA | 0.220 | 0.295 | 0.341 | 0.365 | 0.411 | 0.295 |
FMDV | 0.265 | 0.314 | 0.364 | 0.396 | 0.430 | 0.323 |
FMDV=Foot and mouth disease virus, PHA=Phytohemagglutinin, ΔOD=Delta optical density,